EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Updates on C3 Glomerulopathy in Kidney Transplantation: Pathogenesis and Treatment Options

Giulia Bartoli, Andrea Dello Strologo, Giuseppe Grandaliano, Francesco Pesce iD

International Journal of Molecular Sciences · 13.06.2024 · 25 (12) · 6508

DOI: 10.3390/ijms25126508 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.06.2024. Verfasst von Giulia Bartoli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine and Surgery, Università Cattolica dl Sacro Cuore, 00168 Rome, Italy. Hauptthemen laut MEDLINE: Kidney Transplantation, Complement C3. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

C3 glomerulopathy is a rare disease, characterized by an abnormal activation of the complement’s alternative pathway that leads to the accumulation of the C3 component in the kidney. The disease recurs in more than half of kidney transplant recipients, with a significant impact on graft survival. Recurrence of the primary disease represents the second cause of graft loss after organ rejection. In C3 glomerulopathy, there are several risk factors which can promote a recurrence during transplantation, such as delayed graft function, infection and monoclonal gammopathy. All these events can trigger the alternative complement pathway. In this review, we summarize the impact of C3 glomerulopathy on kidney grafts and present the latest treatment options. The most widely used treatments for the disease include corticosteroids and mycophenolate mofetil, which are already used chronically by kidney transplant recipients; thus, additional treatments for C3 glomerulopathy are required. Currently, several studies using anti-complement drugs (i.e., eculizumab, Ravalizumab, avacopan) for C3 glomerulopathy in kidney transplant patients are ongoing with encouraging results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationComplement C3HumansGraft RejectionGlomerulonephritisMycophenolic Acid

Stichwörter der Autor:innen

C3 glomerulopathyinfectionkidney transplantationmonoclonal gammopathytreatment

Substanzen

Complement C3Mycophenolic Acid

Autor:innen und Institutionen

  • Department of Translational Medicine and Surgery, Università Cattolica dl Sacro Cuore, 00168 Rome, Italy.
  • Nephrology, Dialysis and Transplantation Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
  • Division of Renal Medicine, "Ospedale Isola Tiberina-Gemelli Isola", 00186 Rome, Italy.

ORCID-Profile: Francesco Pesce

Zitieren

APA

Bartoli, G., Dello Strologo, A., Grandaliano, G., & Pesce, F. (2024). Updates on C3 Glomerulopathy in Kidney Transplantation: Pathogenesis and Treatment Options. International Journal of Molecular Sciences, 25(12), 6508. https://doi.org/10.3390/ijms25126508

Vancouver

Bartoli G, Dello Strologo A, Grandaliano G, Pesce F. Updates on C3 Glomerulopathy in Kidney Transplantation: Pathogenesis and Treatment Options. International Journal of Molecular Sciences. 2024;25(12):6508. doi:10.3390/ijms25126508

BibTeX
@article{Bartoli2024,
  author = {Bartoli, Giulia and Dello Strologo, Andrea and Grandaliano, Giuseppe and Pesce, Francesco},
  title = {Updates on C3 Glomerulopathy in Kidney Transplantation: Pathogenesis and Treatment Options},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {12},
  pages = {6508},
  doi = {10.3390/ijms25126508}
}
Kostenlos starten →